Presbyopia

Latest News

April 9th 2021

By Rhett Schiffman, MD, MHSA, Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director, Brooke Henson, Editor

A presbyopia-correcting eyedrop recently received FDA acceptance of its investigational new drug (IND) application

CME Content

Video

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Mark R. Barakat, MD, FASRS; David Eichenbaum, MD, FASRS

Video

(CME Track) Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment

Dilsher Dhoot, MD, FASRS; Jordana G. Fein, MD, MS; Deep Parikh, MD; Xiao-Yi (Ellie) Zhou, MD

Video

(CME Track) A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management

David Almeida, MD, PhD, MBA; Margaret A. Chang, MD, MS; Arshad M. Khanani, MD, MA, FASRS; Jessica Randolph, MD

Video

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

Dante Pieramici, MD, FASRS; Dean Eliott, MD; Robin A. Vora, MD; Charles C. Wykoff, MD, PhD, FASRS

Video

Medical Crossfire®: Maximizing Durability Across Retinal Disease — What 3 Years of Evidence Means for Your Practice

Judy E. Kim, MD, FARVO, FASRS; Anat Loewenstein, MD, MHA; Deepak Sambhara, MD, FASRS

In-Person + Virtual Event

AREDS3 and Beyond: The Scientific Basis for B Vitamin Nutritional Supplementation in AMD

September 13, 2026

Virtual Event

EyeCon 2026

September 26, 2026

In-Person + Virtual Event

Join Us at The Ophthalmology Meeting This October in New Orleans

October 9-11, 2026

Video

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Stephen C. Pflugfelder, MD; Cecelia Koetting, OD, FAAO, DipABO

Video

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Basil Williams, MD; Maura Di Nicola, MD

Video

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Deep Parikh, MD

Video

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

Video

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Uday Devgan, MD, FACS, FRCS

Video

(COPE) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

Damon Dierker, OD FAAO; Maria Pribis, OD

Video

(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

Damon Dierker, OD FAAO; Maria Pribis, OD

Quiz: Treatments for presbyopia coming soon

ByBrooke Henson, Editor

November 19th 2020

quick quiz

Quiz Answers: Treatments for presbyopia coming soon

ByBrooke Henson, Editor

November 19th 2020

Treatments for presbyopia coming soon

ByKhan Lau, OD, MBA, FAAO

November 13th 2020

These options increase the depth of field to address the symptoms of presbyopia

Pipeline: New therapies to come for debilitating eye diseases

ByGretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Bernard Gilly, PhD

November 12th 2020

New drug from Gensight Biologics hits pipeline

Topical presbyopia management: Threat or opportunity?

ByJohn Rumpakis, OD, MBA

October 28th 2020

New technology and management options are going to continue to hit the market. How ODs approach each one of them will determine whether ODs benefit or not.

Presbyopia

Latest News

CME Content

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

(CME Track) Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment

(CME Track) A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

Medical Crossfire®: Maximizing Durability Across Retinal Disease — What 3 Years of Evidence Means for Your Practice

AREDS3 and Beyond: The Scientific Basis for B Vitamin Nutritional Supplementation in AMD

EyeCon 2026

Join Us at The Ophthalmology Meeting This October in New Orleans

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

(COPE) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

Quiz: Treatments for presbyopia coming soon

Quiz Answers: Treatments for presbyopia coming soon

Treatments for presbyopia coming soon

Pipeline: New therapies to come for debilitating eye diseases

Topical presbyopia management: Threat or opportunity?

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

How Lytenava's FDA approval will impact clinical treatment of nAMD

A primer on oral omega-3s and dry eye disease

Perceived stress may precede worsening dry eye symptoms in young adults, study finds

FDA recalls eye drop that relieves ocular itch for potential contamination

Duravyu misses primary end point in first pivotal wet AMD trial; secondary durability signals hold